Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 26 | 2024 | 770 | 3.970 |
Why?
|
| Smoking | 18 | 2024 | 2549 | 1.900 |
Why?
|
| Depressive Disorder | 8 | 2014 | 567 | 1.470 |
Why?
|
| Pregnancy Complications | 4 | 2013 | 541 | 0.940 |
Why?
|
| Nicotinic Agonists | 3 | 2024 | 120 | 0.840 |
Why?
|
| Tobacco Use Disorder | 7 | 2024 | 300 | 0.830 |
Why?
|
| Self Efficacy | 3 | 2019 | 297 | 0.710 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2013 | 255 | 0.660 |
Why?
|
| Depressive Disorder, Major | 8 | 2022 | 439 | 0.650 |
Why?
|
| Health Behavior | 3 | 2022 | 599 | 0.650 |
Why?
|
| Panic Disorder | 2 | 2016 | 53 | 0.630 |
Why?
|
| Smoking Prevention | 5 | 2013 | 143 | 0.560 |
Why?
|
| Counseling | 3 | 2018 | 380 | 0.530 |
Why?
|
| Nicotine | 3 | 2024 | 265 | 0.500 |
Why?
|
| Webcasts as Topic | 1 | 2013 | 9 | 0.450 |
Why?
|
| Neoplasms | 10 | 2024 | 15951 | 0.430 |
Why?
|
| Varenicline | 3 | 2024 | 72 | 0.420 |
Why?
|
| Cancer Survivors | 1 | 2019 | 747 | 0.400 |
Why?
|
| Exercise | 1 | 2019 | 1221 | 0.390 |
Why?
|
| Social Support | 1 | 2013 | 585 | 0.360 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2008 | 219 | 0.320 |
Why?
|
| Child Abuse | 1 | 2011 | 208 | 0.310 |
Why?
|
| Antidepressive Agents, Second-Generation | 6 | 2009 | 62 | 0.290 |
Why?
|
| Triazoles | 6 | 2009 | 629 | 0.260 |
Why?
|
| Precision Medicine | 1 | 2013 | 1216 | 0.260 |
Why?
|
| Affect | 3 | 2014 | 306 | 0.230 |
Why?
|
| Behavior Therapy | 3 | 2022 | 302 | 0.230 |
Why?
|
| Adult | 27 | 2024 | 82073 | 0.220 |
Why?
|
| Smokers | 2 | 2022 | 154 | 0.220 |
Why?
|
| Vaping | 1 | 2023 | 45 | 0.210 |
Why?
|
| Motivation | 3 | 2014 | 515 | 0.210 |
Why?
|
| Bupropion | 3 | 2022 | 77 | 0.210 |
Why?
|
| Tobacco Use | 3 | 2023 | 63 | 0.210 |
Why?
|
| Depression | 6 | 2022 | 1733 | 0.210 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2023 | 77 | 0.200 |
Why?
|
| Tobacco Products | 1 | 2023 | 157 | 0.200 |
Why?
|
| Dysthymic Disorder | 3 | 2009 | 10 | 0.200 |
Why?
|
| Female | 34 | 2024 | 148936 | 0.190 |
Why?
|
| Patient Education as Topic | 3 | 2019 | 746 | 0.180 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 603 | 0.180 |
Why?
|
| Middle Aged | 20 | 2024 | 90569 | 0.170 |
Why?
|
| Pregnancy | 8 | 2014 | 7916 | 0.170 |
Why?
|
| Directive Counseling | 1 | 2019 | 41 | 0.170 |
Why?
|
| Humans | 41 | 2024 | 270804 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2024 | 697 | 0.160 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 214 | 0.160 |
Why?
|
| Male | 26 | 2024 | 128520 | 0.150 |
Why?
|
| Time Factors | 7 | 2024 | 12979 | 0.140 |
Why?
|
| Tobacco Use Cessation | 1 | 2016 | 29 | 0.140 |
Why?
|
| Chronic Disease | 6 | 2013 | 1825 | 0.130 |
Why?
|
| Comorbidity | 4 | 2013 | 2393 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 19 | 0.120 |
Why?
|
| Demography | 2 | 2013 | 432 | 0.120 |
Why?
|
| Telomere Shortening | 1 | 2014 | 56 | 0.120 |
Why?
|
| Health Promotion | 2 | 2013 | 508 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2014 | 147 | 0.110 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2013 | 8 | 0.110 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 5924 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 601 | 0.110 |
Why?
|
| Computer-Assisted Instruction | 1 | 2013 | 84 | 0.110 |
Why?
|
| Postpartum Period | 2 | 2013 | 257 | 0.110 |
Why?
|
| Life Change Events | 1 | 2013 | 79 | 0.110 |
Why?
|
| Treatment Outcome | 9 | 2024 | 33859 | 0.100 |
Why?
|
| Young Adult | 5 | 2019 | 22255 | 0.100 |
Why?
|
| Psychotherapy | 1 | 2013 | 252 | 0.090 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 249 | 0.090 |
Why?
|
| Adaptation, Psychological | 3 | 2011 | 783 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2024 | 13422 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 319 | 0.090 |
Why?
|
| Electronic Health Records | 2 | 2015 | 853 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4495 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2014 | 2442 | 0.080 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 67 | 0.080 |
Why?
|
| Age of Onset | 1 | 2011 | 853 | 0.080 |
Why?
|
| Self Report | 1 | 2013 | 794 | 0.080 |
Why?
|
| Students | 1 | 2011 | 334 | 0.080 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2008 | 39 | 0.080 |
Why?
|
| Texas | 2 | 2016 | 6445 | 0.070 |
Why?
|
| Aged | 10 | 2024 | 73640 | 0.070 |
Why?
|
| Personality Disorders | 1 | 2009 | 165 | 0.070 |
Why?
|
| Audiovisual Aids | 1 | 2006 | 40 | 0.070 |
Why?
|
| Research Design | 1 | 2013 | 1562 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2006 | 127 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2659 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 4396 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 448 | 0.060 |
Why?
|
| Self Care | 1 | 2006 | 249 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2024 | 2575 | 0.060 |
Why?
|
| Defense Mechanisms | 1 | 2003 | 19 | 0.060 |
Why?
|
| Piperazines | 6 | 2009 | 2143 | 0.050 |
Why?
|
| Professional-Patient Relations | 1 | 2003 | 112 | 0.050 |
Why?
|
| Psychometrics | 2 | 2005 | 975 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 15280 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2022 | 40 | 0.050 |
Why?
|
| Polyesters | 1 | 2022 | 68 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 10409 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2024 | 1430 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2000 | 75 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 966 | 0.040 |
Why?
|
| Adolescent Psychiatry | 1 | 1999 | 17 | 0.040 |
Why?
|
| Anxiety | 2 | 2014 | 1244 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2010 | 907 | 0.040 |
Why?
|
| Health Education | 2 | 2011 | 302 | 0.040 |
Why?
|
| Adolescent | 5 | 2011 | 32698 | 0.040 |
Why?
|
| Combined Modality Therapy | 5 | 2009 | 9054 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 599 | 0.040 |
Why?
|
| Emotions | 1 | 2021 | 558 | 0.040 |
Why?
|
| Child | 4 | 2021 | 30572 | 0.040 |
Why?
|
| Personality Inventory | 2 | 2009 | 195 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 772 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 352 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 572 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2014 | 179 | 0.030 |
Why?
|
| Recurrence | 3 | 2009 | 4878 | 0.020 |
Why?
|
| CD-ROM | 1 | 2011 | 11 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 6193 | 0.020 |
Why?
|
| Cause of Death | 1 | 2014 | 782 | 0.020 |
Why?
|
| Poverty | 1 | 2014 | 485 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 5053 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 1061 | 0.020 |
Why?
|
| United States | 2 | 2021 | 15834 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 930 | 0.020 |
Why?
|
| Risk Factors | 1 | 2006 | 17867 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 237 | 0.020 |
Why?
|
| Problem Solving | 1 | 2009 | 87 | 0.020 |
Why?
|
| Culture | 1 | 2009 | 104 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2855 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1308 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 2313 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 2300 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 1557 | 0.010 |
Why?
|
| Psychology, Child | 1 | 1984 | 45 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 455 | 0.010 |
Why?
|
| Internal-External Control | 1 | 2003 | 110 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 5050 | 0.010 |
Why?
|
| Attitude | 1 | 1984 | 161 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 141 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 2560 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 1564 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 4249 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2003 | 277 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 6234 | 0.010 |
Why?
|
| Learning | 1 | 2003 | 438 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 9464 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2000 | 295 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2000 | 602 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 5779 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 39982 | 0.010 |
Why?
|
| Sex Factors | 1 | 1999 | 2180 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 9281 | 0.010 |
Why?
|
| Hospitalization | 1 | 1999 | 2170 | 0.010 |
Why?
|
| Prejudice | 1 | 1984 | 50 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1984 | 17083 | 0.000 |
Why?
|